Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07413055

Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial

Comparative Efficacy of 4 mg vs. 8 mg Submucosal Dexamethasone in Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
138 (estimated)
Sponsor
Oman Ministry of Health · Other Government
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the effectiveness of 4mg and 8mg dexamethasone administered submucosally in reducing postoperative pain after dental implant surgery. Participants will be randomly assigned to receive either 4mg dexamethasone, 8mg dexamethasone, or a placebo (normal saline) at the surgical site. Later, postoperative pain will be assessed using a Visual Analog Scale at 6 hours after the surgery and daily for the next 6 days. Also the number of pain-relief tablets consumed after the surgery will be recorded. Preoperative anxiety will be assessed using Generalized Anxiety Disorder-7 (GAD-7) questionnaire to assess its association with postoperative pain scores. The results of this study will help determine the optimal dose of dexamethasone that is effective for postoperative pain control following dental implant surgery.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone 4 Mg/mL Injectable SolutionSyringe will be concealed. Submucosal injection will be adjacent to the surgical site in the buccal vestibule
DRUGDexamethasone 8Mg Solution for InjectionSyringe will be concealed. Submucosal injection will be adjacent to the surgical site in the buccal vestibule
DRUGSaline (NaCl 0,9 %) (placebo)Syringe will be concealed. Submucosal injection will be adjacent to the surgical site in the buccal vestibule

Timeline

Start date
2026-03-25
Primary completion
2026-11-15
Completion
2026-12-01
First posted
2026-02-17
Last updated
2026-03-30

Locations

1 site across 1 country: Oman

Source: ClinicalTrials.gov record NCT07413055. Inclusion in this directory is not an endorsement.